Goldman Sachs
TECX

Goldman Sachs’s Tectonic Therapeutic TECX Stock Holding History

Goldman Sachs’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
73,924
+11,498
+18% +$338K ﹤0.01% 4480
2026
Q1 		$1.93M Sell
62,426
-30,277
-33% -$745K ﹤0.01% 4573
2025
Q4 		$1.93M Sell
92,703
-4,163
-4% -$77.4K ﹤0.01% 4616
2025
Q3 		$1.52M Buy
+96,866
New +$2M ﹤0.01% 4713
2025
Q2 		– Sell
-104,793
Closed -$1.86M – 6512
2025
Q1 		$1.86M Buy
104,793
+80,483
+331% +$2.62M ﹤0.01% 4219
2024
Q4 		$1.12M Buy
+24,310
New +$1.03M ﹤0.01% 4742
2023
Q1 		– Sell
-840
Closed -$7.19K – 6287
2022
Q4 		$7.19K Sell
840
-58,063
-99% -$511K ﹤0.01% 5780
2022
Q3 		$454K Buy
58,903
+46,532
+376% +$517K ﹤0.01% 5044
2022
Q2 		$136K Sell
12,371
-10,275
-45% -$121K ﹤0.01% 5765
2022
Q1 		$359K Sell
22,646
-92,501
-80% -$1.91M ﹤0.01% 5545
2021
Q4 		$5.32M Buy
115,147
+79,135
+220% +$4.55M ﹤0.01% 3348
2021
Q3 		$2.41M Buy
36,012
+3
+0% +$246 ﹤0.01% 4011
2021
Q2 		$3.84M Buy
36,009
+7,947
+28% +$942K ﹤0.01% 3583
2021
Q1 		$4.27M Sell
28,062
-12,338
-31% -$2.01M ﹤0.01% 3270
2020
Q4 		$6.76M Buy
40,400
+2,602
+7% +$463K ﹤0.01% 2776
2020
Q3 		$5.91M Buy
37,798
+8,692
+30% +$1.75M ﹤0.01% 2767
2020
Q2 		$6.09M Buy
29,106
+21,514
+283% +$4.43M ﹤0.01% 2649
2020
Q1 		$1.42M Buy
7,592
+538
+8% +$127K ﹤0.01% 3522
2019
Q4 		$1.7M Sell
7,054
-534
-7% -$103K ﹤0.01% 3759
2019
Q3 		$1.28M Buy
7,588
+1,242
+20% +$281K ﹤0.01% 3863
2019
Q2 		$1.24M Sell
6,346
-166
-3% -$35.8K ﹤0.01% 3854
2019
Q1 		$1.72M Buy
6,512
+4,711
+262% +$861K ﹤0.01% 3736
2018
Q4 		$360K Buy
+1,801
New +$549K ﹤0.01% 4549
2018
Q3 		– Sell
-4,373
Closed -$1.5M – 5824
2018
Q2 		$1.5M Buy
+4,373
New +$1.58M ﹤0.01% 3811

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Goldman Sachs's TECX Position: Q2 2026 in Review

Goldman Sachs increased its Tectonic Therapeutic (TECX) stake by 18% in Q2 2026, buying an estimated $338K and bringing the position to 73,924 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #4480.

Goldman Sachs first reported a position in TECX in Q2 2018 and has held it in 24 quarters since. The position peaked at $6.76M in Q4 2020. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Goldman Sachs held 73,924 shares of Tectonic Therapeutic worth $2.54M as of Q2 2026.
  • Goldman Sachs bought 11,498 Tectonic Therapeutic shares in Q2 2026, an estimated $338K.
  • Tectonic Therapeutic made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4480 holding.
  • Goldman Sachs first reported a position in Tectonic Therapeutic in Q2 2018 and has held it in 24 quarters since.
  • Goldman Sachs's Tectonic Therapeutic position peaked at $6.76M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.